
Journal of Medicinal Chemistry p. 2591 - 2600 (1992)
Update date:2022-08-04
Topics:
Lowe, John A.
Drozda, Suzan E.
Snider, R. Michael
Longo, Kelly P.
Zorn, Stevin H.
et al.
We describe the structure-activity relationship development of a series of quinuclidines which culminated in the first potent, selective, nonpeptide substance P (SP) antagonist, (2S,3S)-cis-2-(diphenylmethyl)-N-<(2-methoxyphenyl)methyl>-1-azabicyclo<2.2.2
View MoreChangzhou Anyi Biochem Co., Ltd.(expird)
Contact:+86-519-88836158
Address:no,51 caoda
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
website:http://www.orchid-chem.com
Contact:+86-571-85395792
Address:607, North Zhongshan Road, Hangzhou 310000 China
Doi:10.1021/ja00975a028
(1966)Doi:10.1016/S0040-4039(00)78885-X
(1992)Doi:10.1021/ol303546p
(2013)Doi:10.1039/c2ob27221k
(2013)Doi:10.1021/ml300321d
(2013)Doi:10.1039/c2ce25841b
(2012)